Cargando…
Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis
BACKGROUND: Metformin, a first line antihyperglycemic medication, is an AMPK activator and has been hypothesized to act as a geroprotective agent. Studies on its association with various classifications of age-related cognitive decline have shown mixed results with positive and negative findings. OB...
Autores principales: | Campbell, Jared M., Stephenson, Matthew D., de Courten, Barbora, Chapman, Ian, Bellman, Susan M., Aromataris, Edoardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6218120/ https://www.ncbi.nlm.nih.gov/pubmed/30149446 http://dx.doi.org/10.3233/JAD-180263 |
Ejemplares similares
-
Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence
por: Barker, Timothy Hugh, et al.
Publicado: (2021) -
What kind of systematic review should I conduct? A proposed typology and guidance for systematic reviewers in the medical and health sciences
por: Munn, Zachary, et al.
Publicado: (2018) -
Supporting a definition of predatory publishing
por: Aromataris, Edoardo, et al.
Publicado: (2020) -
Metformin and the Risk of Dementia in Type 2 Diabetes Patients
por: Chin-Hsiao, Tseng
Publicado: (2019) -
Potentially inappropriate prescribing and its associations with health‐related and system‐related outcomes in hospitalised older adults: A systematic review and meta‐analysis
por: Mekonnen, Alemayehu B, et al.
Publicado: (2021)